Tatva Chintan Pharma Chem IPO Subscription Status
Tatva Chintan Pharma Chem IPO was subscribed 182.04 times when bidding closed on 20 Jul 2021: QIB 186.96x, NII 516.99x, Retail 35.68x.
The Tatva Chintan Pharma Chem IPO has been subscribed 182.04x times overall. Retail investors have shown interest with bids for 35.68x the shares available. The Non-Institutional Investor (NII) category has been subscribed 516.99x. Qualified Institutional Buyers (QIBs) have subscribed 186.96x. Data last updated on 10 Nov, 07:18 AM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 16 Jul, 2021 and closes on 20 Jul, 2021. The shares are expected to list on stock exchanges on 29 Jul, 2021.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 186.96x |
| NII | - of - - | 516.99x |
| Retail | - of - - | 35.68x |
| TOTAL | - - | 182.04x |
Tatva Chintan Pharma Chem IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 36 applicants will be successful.
Market Sentiment
Strong grey market premium of 106% suggests exceptional listing gains and high bullish sentiment among traders.
Institutional Backing
Massive institutional interest with QIBs subscribing 186.96x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
20 Jul 2021
Day 3 |
182.04x | ▼ | |
|
QIB186.96x
BHNI-
SHNI-
Retail35.68x
|
|||
|
19 Jul 2021
Day 2 |
15.05x | ▼ | |
|
QIB1.97x
BHNI-
SHNI-
Retail23.74x
|
|||
|
16 Jul 2021
Day 1 |
4.51x | ▼ | |
|
QIB0.51x
BHNI-
SHNI-
Retail8.25x
|
|||
Tatva Chintan Pharma Chem IPO dates
From the bidding window to listing. Today is 11 November.
- Open 16 Jul 2021
- Close 20 Jul 2021
- Allotment 26 Jul 2021
- Refund/credit 27 Jul 2021
- Listing 29 Jul 2021
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Tatva Chintan Pharma Chem IPO?
As of IPO close date (20 Jul, 2021), the Tatva Chintan Pharma Chem IPO is subscribed 182.04x times. Retail category is 35.68x, and NII is 516.99x subscribed.
When is the allotment date for Tatva Chintan Pharma Chem IPO?
The allotment for Tatva Chintan Pharma Chem IPO is expected to be finalized on 26 July, 2021.
What is the GMP of Tatva Chintan Pharma Chem?
The Grey Market Premium (GMP) for Tatva Chintan Pharma Chem is currently ₹1150, indicating a potential listing gain of 106%.
When will Tatva Chintan Pharma Chem IPO list on the stock market?
Tatva Chintan Pharma Chem is scheduled to list on BSE and NSE on 29 July, 2021.
What are the chances of getting allotment in Tatva Chintan Pharma Chem IPO?
The retail category is oversubscribed at 35.68x, meaning allotment is by lottery. Statistically, approximately 1 in 36 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 186.96x mean for Tatva Chintan Pharma Chem IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 186.96x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Tatva Chintan Pharma Chem IPO allotment status?
After the allotment date (26 Jul, 2021), you can check your Tatva Chintan Pharma Chem IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Tatva Chintan Pharma Chem IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
